OBIO
Orchestra BioMed·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OBIO fundamentals
Orchestra BioMed (OBIO) released its earnings on Aug 12, 2025: revenue was 836.00K (YoY +7.46%), beat estimates; EPS was -0.5 (YoY -11.11%), beat estimates.
Revenue / YoY
836.00K
+7.46%
EPS / YoY
-0.5
-11.11%
Report date
Aug 12, 2025
Earnings Call
3:00 PM on Aug 11, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
OBIO has released its 2025 Q3 earnings report, with revenue of 861.00K, reflecting a YoY change of -12.77%, and net profit of -20.83M, showing a YoY change of -35.02%. The Sankey diagram below clearly presents OBIO's revenue sources and cost distribution.
Key Indicators
Orchestra BioMed (OBIO) key financial stats and ratios, covering profitability, financial health, and leverage.
Orchestra BioMed (OBIO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Orchestra BioMed (OBIO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Orchestra BioMed (OBIO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Orchestra BioMed (OBIO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Orchestra BioMed (OBIO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Orchestra BioMed's revenue and profit?What is the market's earnings forecast for Orchestra BioMed next quarter?What does Orchestra BioMed do and what are its main business segments?What were the key takeaways from Orchestra BioMed's earnings call?What is Orchestra BioMed's gross profit margin?What is the revenue and EPS growth rate for Orchestra BioMed year over year?What were the key takeaways from Orchestra BioMed’s earnings call?Did Orchestra BioMed beat or miss consensus estimates last quarter?
